IGF1R and cholangiocarcinoma: Recently was shown that CC express estrogens receptor (ER–α and –β) directly linked with insulin-like growth factor 1 (IGF1) and IGF1-R (receptor) [21], which could represent a strategy for the management of cholangiocarcinoma.